Skip to main content
. 2014 Jul 16;41(2):366–373. doi: 10.1093/schbul/sbu101

Table 2.

Demographics Information From Experiment 2

Healthy Controlsa Schizophrenia Patientsb
Gender (M:F) 22:14 28:14
Age 38.28±11.94 39.98±10.10
Race (AA:C:other) 13:21:2 16:23:3
Education (years) 15.11±1.91 13.05±2.32***
Parental education 14.21±2.08 13.55±2.65
Haloperidol dose equivalent (mg/day) 10.53±7.85
BPRS 37.32±7.09
WASI 118.00±8.63 97.83±13.51***
MATRICS total 54.35±8.38 30.18±14.13***
WRAT-4 111.59±13.77 96.05±11.39***
WTAR 113.50±10.46 98.85±14.26***

Note: Abbreviations are explained in the first footnote to table 1.

aCognitive testing is not available for 4 healthy control participants.

bCognitive testing is not available for 2 schizophrenia patients.

***P < .001.